Franklin Resources
RPTX

Franklin Resources’s Repare Therapeutics RPTX Stock Holding History

Franklin Resources’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-133,773
Closed -$2.82M – 2520
2021
Q4 		$2.82M Sell
133,773
-164,836
-55% -$3.88M ﹤0.01% 1396
2021
Q3 		$7.84M Buy
298,609
+210,074
+237% +$6.79M ﹤0.01% 1104
2021
Q2 		$2.76M Hold
88,535
– – ﹤0.01% 1287
2021
Q1 		$2.72M Sell
88,535
-404,837
-82% -$13.8M ﹤0.01% 1262
2020
Q4 		$16.9M Sell
493,372
-9,973
-2% -$298K 0.01% 852
2020
Q3 		$15.5M Buy
503,345
+1,104
+0.2% +$29.2K 0.01% 826
2020
Q2 		$11.3M Buy
+502,241
New +$16.1M 0.01% 844

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Franklin Resources's RPTX Position: Q1 2022 in Review

Franklin Resources sold out of Repare Therapeutics (RPTX) in Q1 2022, closing a stake of 133,773 shares — an estimated $2.82M sold.

Franklin Resources first reported a position in RPTX in Q2 2020 and held it in 7 quarters. The position peaked at $16.9M in Q4 2020. 62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • Franklin Resources reported no remaining Repare Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Franklin Resources sold 133,773 Repare Therapeutics shares in Q1 2022, an estimated $2.82M.
  • Franklin Resources first reported a position in Repare Therapeutics in Q2 2020 and held it in 7 quarters.
  • Franklin Resources's Repare Therapeutics position peaked at $16.9M in Q4 2020.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on Franklin Resources's 13F filing for Q1 2022, filed 13 May 2022.